Dexcom (DXCM) EBT (2010 - 2026)

Dexcom (DXCM) has 17 years of EBT data on file, last reported at $269.5 million in Q1 2026.

• On a quarterly basis, EBT rose 74.66% year-over-year to $269.5 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 64.7% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 53.51% from the prior year.
• EBT for Q1 2026 stood at $269.5 million, down from $340.7 million in the prior quarter.
• Over the last five years, EBT for DXCM reached as high as $352.3 million in Q3 2025 and fell as low as $36.1 million in Q1 2022.
• Historically, EBT has averaged $186.4 million across 5 years, with a median of $177.4 million in 2024.
• Across the five-year window, EBT soared 1981.25% in 2022 and retreated 26.21% in 2024, its largest moves.
• Year by year, EBT stood at $133.2 million in 2022, then soared by 84.83% to $246.2 million in 2023, then declined by 14.18% to $211.3 million in 2024, then jumped by 61.24% to $340.7 million in 2025, then declined by 20.9% to $269.5 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $269.5 million in Q1 2026, $340.7 million in Q4 2025, and $352.3 million in Q3 2025.